peroxynitrous acid has been researched along with benzyloxycarbonylleucyl-leucyl-leucine aldehyde in 5 studies
Studies (peroxynitrous acid) | Trials (peroxynitrous acid) | Recent Studies (post-2010) (peroxynitrous acid) | Studies (benzyloxycarbonylleucyl-leucyl-leucine aldehyde) | Trials (benzyloxycarbonylleucyl-leucyl-leucine aldehyde) | Recent Studies (post-2010) (benzyloxycarbonylleucyl-leucyl-leucine aldehyde) |
---|---|---|---|---|---|
3,303 | 21 | 1,230 | 2,473 | 3 | 1,057 |
Protein | Taxonomy | peroxynitrous acid (IC50) | benzyloxycarbonylleucyl-leucyl-leucine aldehyde (IC50) |
---|---|---|---|
Proteasome subunit beta type-11 | Homo sapiens (human) | 1.9893 | |
Calpain-9 | Homo sapiens (human) | 9.88 | |
Proteasome subunit alpha type-7 | Homo sapiens (human) | 1.9893 | |
Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | 3.9 | |
Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 3.8999 | |
Aromatase | Homo sapiens (human) | 0.044 | |
Indoleamine 2,3-dioxygenase 1 | Homo sapiens (human) | 0.5 | |
Proteasome subunit beta type-1 | Homo sapiens (human) | 1.0853 | |
Proteasome subunit alpha type-1 | Homo sapiens (human) | 1.9893 | |
Proteasome subunit alpha type-2 | Homo sapiens (human) | 1.9893 | |
Proteasome subunit alpha type-3 | Homo sapiens (human) | 1.9893 | |
Proteasome subunit alpha type-4 | Homo sapiens (human) | 1.9893 | |
Proteasome subunit beta type-8 | Homo sapiens (human) | 1.9893 | |
Proteasome subunit beta type-9 | Homo sapiens (human) | 1.9893 | |
Proteasome subunit alpha type-5 | Homo sapiens (human) | 1.9893 | |
Proteasome subunit beta type-4 | Homo sapiens (human) | 1.9893 | |
Proteasome subunit beta type-6 | Homo sapiens (human) | 1.9893 | |
Proteasome subunit beta type-5 | Homo sapiens (human) | 0.6088 | |
Proteasome subunit beta type-10 | Homo sapiens (human) | 1.9893 | |
Proteasome subunit beta type-3 | Homo sapiens (human) | 1.9893 | |
Proteasome subunit beta type-2 | Homo sapiens (human) | 2.0443 | |
Proteasome subunit alpha type-6 | Homo sapiens (human) | 1.9893 | |
Proteasome subunit alpha-type 8 | Homo sapiens (human) | 1.9893 | |
Proteasome subunit beta type-7 | Homo sapiens (human) | 1.9893 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Song, P; Wang, S; Wu, Y; Xu, J; Zhang, M; Zou, MH | 1 |
Akamatsu, K; Furukawa, K; Hayata, A; Hirano, T; Ichikawa, T; Ichinose, M; Kanda, M; Koarai, A; Matsunaga, K; Minakata, Y; Nakanishi, M; Sugiura, H; Yanagisawa, S | 1 |
Song, P; Wang, S; Wu, Y; Xu, J; Zou, MH | 1 |
Asfa, S; Wang, Q; Wang, S; Xu, J; Zhang, M; Zou, MH | 1 |
Black, SA; Cuddy, LK; Ferguson, SS; Gordon, AC; Jaworski, E; Rylett, RJ | 1 |
5 other study(ies) available for peroxynitrous acid and benzyloxycarbonylleucyl-leucyl-leucine aldehyde
Article | Year |
---|---|
Proteasome-dependent degradation of guanosine 5'-triphosphate cyclohydrolase I causes tetrahydrobiopterin deficiency in diabetes mellitus.
Topics: Animals; Antioxidants; Aorta; Biopterins; Cells, Cultured; Cyclic N-Oxides; Cysteine Proteinase Inhibitors; Diabetes Mellitus, Experimental; Endothelial Cells; Glucose; GTP Cyclohydrolase; Guanosine Triphosphate; Leupeptins; Mice; Mice, Inbred C57BL; Nitrogen; Organ Culture Techniques; Peroxynitrous Acid; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Reactive Oxygen Species; Spin Labels; Tyrosine; Ubiquitin; Umbilical Veins | 2007 |
Peroxynitrite augments fibroblast-mediated tissue remodeling via myofibroblast differentiation.
Topics: Actins; Antibodies; Cell Differentiation; Cell Nucleus; Cells, Cultured; Collagen Type I; Desmin; Fetus; Fibroblasts; Fibronectins; Humans; Leupeptins; Lung; Molsidomine; Myoblasts; Neutralization Tests; NF-kappa B; Peroxynitrous Acid; Protein Transport; Transforming Growth Factor beta | 2008 |
Tyrosine nitration of PA700 activates the 26S proteasome to induce endothelial dysfunction in mice with angiotensin II-induced hypertension.
Topics: Angiotensin II; Animals; Aorta; Biopterins; Blood Pressure; Cells, Cultured; Cysteine Proteinase Inhibitors; Endothelial Cells; Endothelium, Vascular; GTP Cyclohydrolase; Humans; Hypertension; In Vitro Techniques; Leupeptins; Mice; Mice, Inbred C57BL; Nitrates; Peroxynitrous Acid; Proteasome Endopeptidase Complex; Proteasome Inhibitors; RNA, Small Interfering; Transfection; Tyrosine; Vasodilation | 2009 |
Tyrosine nitration of PA700 links proteasome activation to endothelial dysfunction in mouse models with cardiovascular risk factors.
Topics: Animals; Blotting, Western; Cardiovascular Diseases; Cells, Cultured; Cysteine Proteinase Inhibitors; Diabetes Mellitus, Experimental; Dyslipidemias; Endothelium, Vascular; Enzyme Activation; Human Umbilical Vein Endothelial Cells; Humans; Hypertension; Leupeptins; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitrosation; Peroxynitrous Acid; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Subunits; Receptors, LDL; Risk Factors; RNA Interference; Thioredoxins; Tyrosine | 2012 |
Peroxynitrite donor SIN-1 alters high-affinity choline transporter activity by modifying its intracellular trafficking.
Topics: Cell Line, Transformed; Cell Line, Tumor; Choline; Clathrin; Cysteine Proteinase Inhibitors; Dose-Response Relationship, Drug; Endocytosis; Endosomes; Hemicholinium 3; Humans; Leupeptins; Luminescent Proteins; Lysosomes; Membrane Transport Proteins; Molsidomine; Mutation; Neuroblastoma; Nitric Oxide; Nitric Oxide Donors; Peroxynitrous Acid; Protein Transport; rab5 GTP-Binding Proteins; Time Factors; Transfection; Tritium; Ubiquitination | 2012 |